Literature DB >> 23652037

Usefulness of lumen area parameters determined by intravascular ultrasound to predict functional significance of intermediate coronary artery stenosis.

Ming Cui1, Dan Zhu, Li-jun Guo, Li-ying Song, Yong-zhen Zhang, Fu-chun Zhang, Jie Niu, Gui-song Wang, Jiang-li Han, Wei Gao.   

Abstract

BACKGROUND: Coronary artery disease is the leading cause of death in China. Percutaneous coronary intervention is a recent milestone technology for treatment coronary artery disease. However, clinical decision making for patients with intermediate coronary stenosis is still controversial. We designed this study to assess the optimal intravascular ultrasound (IVUS) criteria for predicting functional significance of intermediate coronary lesions.
METHODS: We enrolled 141 patients with 165 intermediate coronary lesions located in vessels with a diameter ≥ 2.50 mm. IVUS of intermediate coronary lesions were performed before intervention. Pressure-derived fractional flow reserve (FFR) was measured at maximal hyperemia induced by adenosine infusion. An FFR < 0.80 was considered as abnormal functional significance.
RESULTS: For the overall 165 lesions, the mean FFR value was 0.84 ± 0.09. The diameter of the stenosis by visual estimation on angiogram was (59.63 ± 11.29)%. Minimum lumen diameter (MLD), minimum lumen area (MLA) and plaque burden (PB) were (2.00 ± 0.36) mm, (3.88 ± 1.34) mm(2), (67.28 ± 9.89)% respectively by IVUS measurements. An FFR < 0.80 was seen in 43 lesions (30.5%). There was a moderate correlation between IVUS parameters and FFR, including MLD (r = 0.372, P < 0.001), MLA (r = 0.442, P < 0.001) and PB (r = -0.172, P < 0.05). MLA was a predictor for FFR as a continuous variable independent of possible confounding variables (P < 0.05), and MLA and PB, were predictors for FFR < 0.80 as binary variables (P < 0.05). The best cutoff value of MLA to predict FFR < 0.80 was < 3.15 mm(2), with a 73.6% diagnostic accuracy; sensitivity 71.4%, specificity 67.0%, AUC = 0.709, and P < 0.001. The cutoff value of the PB to predict FFR < 0.80 was 65.45%; sensitivity 82.6%, specificity 41.2%, AUC = 0.644, and P < 0.01. If both MLA and PB were taken into account, the negative predictive value and the positive predictive value were 88.7% and 64.8% respectively.
CONCLUSIONS: Anatomic measurements of intermediate coronary lesions obtained by IVUS showed a moderate correlation to FFR values. IVUS-derived MLA ≥ 3.15 mm(2) may be useful to exclude FFR < 0.80, but poor specificity limits its applicability for physiological assessment of lesions < 3.15 mm(2). MLA was one of many factors affecting coronary flow hemodynamics. Both MLA and PB should be taken into account when determining functional ischemia.

Entities:  

Mesh:

Year:  2013        PMID: 23652037

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

Review 1.  Impact of plaque characteristics on the degree of functional stenosis.

Authors:  Pedro de Araújo Gonçalves; Alexandre Hideo-Kajita; Hector Manuel Garcia-Garcia
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

Review 2.  The Continuum of Invasive Techniques for the Assessment of Intermediate Coronary Lesions.

Authors:  Nicoleta-Monica Popa-Fotea; Alexandru Scafa-Udriste; Maria Dorobantu
Journal:  Diagnostics (Basel)       Date:  2022-06-18

Review 3.  Critical analysis of the correlation between optical coherence tomography versus intravascular ultrasound and fractional flow reserve in the management of intermediate coronary artery lesion.

Authors:  Yan-Feng Ma; Jiang-Ming Fam; Bu-Chun Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  Diagnostic Performance of Intravascular Ultrasound-Derived Minimal Lumen Area to Predict Functionally Significant Non-Left Main Coronary Artery Disease: a Meta-Analysis.

Authors:  Jae-Sik Jang; Ho-Cheol Shin; Jong Seok Bae; Han-Young Jin; Jeong-Sook Seo; Tae-Hyun Yang; Dae-Kyeong Kim; Kyoung-Im Cho; Bo-Hyun Kim; Yong Hyun Park; Hyung-Gon Je; Dong-Soo Kim
Journal:  Korean Circ J       Date:  2016-09-28       Impact factor: 3.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.